Category: Samsung Electronics Co. Ltd.
Samsung's new Galaxy S5 smartphone features a heart rate sensor, and South Korean regulators are reviewing the technology to determine whether it qualifies as as medical device.
MASSDEVICE ON CALL — South Korean healthcare regulators are taking a closer look at Samsung's (LON:BC94) new Galaxy S5 smartphone in order to determine whether the built-in heart rate sensor turns the phone into a medical device.
Carestream Health lands 510(k) clearance from the FDA for its Vue Motion X-ray app for mobile devices made by tech giants Apple and Samsung.
Carestream Health said it landed 510(k) clearance from the FDA for its new Vue Motion mobile app for Apple and Samsung mobile device platforms.
The app gives physicians mobile access to X-ray exams using Apple's iPhone 4 and iPad 2 devices, as well as the Galaxy Note and Galaxy S III devices made by Samsung.
Samsung plans this April to launch a new model of its Gear smartwatch featuring a heart rate sensor, even as rival smartphone maker Apple refuses to acknowledge rumors of its mHealth pursuits.
MASSDEVICE ON CALL — Technology giant Samsung (LON:BC94) announced new healthcare features for upcoming models of its Gear smartphone-connected watches, which will include heart rate sensors and the company's FDA-cleared S Health app.
Samsung wins clearance for its S Health health monitoring app for smartphones.
Samsung Electronics (LON:BC94) said it landed 510(k) clearance from the FDA for its S Health app.
The S Health app pulls biometric variables from 3rd-party devices, including calories burned, projected heart rate, blood glucose, blood pressure and sleep efficiency.
Texas mHealth company AirStrip partners with mobile technology giant Samsung to optimize the AirStrip ONE mobile interoperability solution for Samsung's tablets and PCs.
Global electronics giant Samsung acquires imaging devices maker NeuroLogica in a stealthy deal that further expands Samsung's growing interest in the medtech space.
Technology titan Samsung Electronics (LON:BC94) made new moves in the medical device space with the stealthy buyout of Danvers, Mass.-based imaging devices maker NeuroLogica.
Covidien agrees to acquire esophageal radiofrequency ablation device maker Barrx for $325 million in a deal expected to close by January 31, 2012.
Covidien (NYSE:COV) agreed to acquire Sunnyvale, Calif.-based device maker Barrx Medical Inc. for $325 million.
Barrx, a private company, specializes in minimally invasive radiofrequency ablation systems that target precancerous tissue in the esophagus.